Heart Failure
Advertisement
The CardioNerds and colleagues review the differential diagnosis for peripartum cardiomyopathy.
The CardioNerds discuss a case involving a patient who presented with stress cardiomyopathy leading to cardiogenic shock.
The U.S. FDA recently approved Attruby (acoramidis) for adults with ATTR-CM to reduce cardiovascular death, hospitalization.
A study highlights the significant HCRU and costs associated with ATTR-CM.
Promising long-term outcomes from the ongoing OLE of the ATTRibute-CM trial highlight the efficacy of acoramidis.
A case study highlights the importance of avoiding anchoring bias in the diagnosis of cardiac amyloidosis.
The diagnosis of AL amyloidosis requires a high index of suspicion to render a prompt diagnosis and appropriate treatment.
A study further supports the efficacy of acoramidis in the treatment of people with ATTR-CM.
People with amyloidosis have a significantly higher prevalence of atrial fibrillation.
An AI model for detecting ATTR-CA yields solid diagnostic results.
On average, the readability of patient educational materials on cardiac amyloidosis fails to meet NIH standards.
A deep-learning model is able to detect ATTR-CM with robust efficacy.
The CardioNerds and Dr. Mark Drazner discuss the correct heart failure status for a 50-year-old woman with a history of CHF.
Artificial intelligence-enhanced ECG models can effectively detect cardiac amyloidosis.
Individuals with transthyretin amyloid cardiomyopathy who have clonal hematopoiesis have an increased risk of mortality.
CLEAR SYNERGY is the largest trial to date on colchicine treatment in myocardial infarction.
The CardioNerds and Dr. Minnow Walsh discuss Dr. Walsh's personal and professional journey in cardiology.
Researchers have developed a novel blood test that can diagnose a heart attack within minutes.
COVID-19 infection may increase the risk of heart attack, stroke and all-cause mortality up to three years post-infection.
BridgeBio Pharma announced this week outcomes from the ATTRibute-CM study will be shared at AHA 2024.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.